Heart failure & cardiomyopathies
Early Outcomes in Patients With LVAD Undergoing Heart Transplant via Use of the SherpaPak Cardiac Transport System
Authors' conclusion
SherpaPak use was associated with improved early post-HT outcomes among patients with LVAD undergoing HT.
Study context
- Population
- Patients with durable LVAD undergoing heart transplant
- Participants
- 149 vs 178
- Exposure
- SherpaPak vs traditional cold storage
- SherpaPakn = 149
- Traditional cold storagen = 178reference
- Outcome
- Primary graft dysfunction (PGD)
Methodological detailsmulticentre registry, propensity matched analysis
- Multicentre registry
- Propensity matched analysis
Main finding
As reported in the abstract
SherpaPak vs Traditional cold storageAdjusted odds ratio (95% CI)P value
PGD
0.56(0.32–0.99)
P = 0.045Severe PGD
0.31(0.13–0.75)
P = 0.009Observational data: associations, not effects.
Further findings
ICU length of stay (propensity matched) · trend · propensity matched analysis
P = 0.09
Hospital length of stay (propensity matched) · trend · propensity matched analysis
P = 0.06
30-day and 1-year survival
- Similar between groups
Original publication
Early Outcomes in Patients With LVAD Undergoing Heart Transplant via Use of the SherpaPak Cardiac Transport System. Circ Heart Fail. Published 11 April 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →